Wall Street brokerages predict that Amdocs Limited (NASDAQ:DOX) will post sales of $1.01 billion for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Amdocs’ earnings. The highest sales estimate is $1.01 billion and the lowest is $1.00 billion. Amdocs reported sales of $977.71 million in the same quarter last year, which would indicate a positive year over year growth rate of 3.3%. The firm is expected to report its next earnings report on Tuesday, January 29th.
According to Zacks, analysts expect that Amdocs will report full year sales of $4.09 billion for the current financial year, with estimates ranging from $4.07 billion to $4.09 billion. For the next year, analysts anticipate that the firm will report sales of $4.22 billion, with estimates ranging from $4.17 billion to $4.26 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research firms that that provide coverage for Amdocs.
Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Thursday, November 8th. The technology company reported $0.90 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.02). Amdocs had a return on equity of 15.06% and a net margin of 8.92%. The firm had revenue of $1 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same period in the previous year, the company posted $0.94 earnings per share. The company’s quarterly revenue was up 2.3% compared to the same quarter last year.
A number of equities research analysts have recently issued reports on the stock. BidaskClub downgraded shares of Amdocs from a “sell” rating to a “strong sell” rating in a report on Thursday, August 30th. Zacks Investment Research raised shares of Amdocs from a “sell” rating to a “hold” rating in a report on Monday, August 20th. Finally, TheStreet downgraded shares of Amdocs from a “b” rating to a “c+” rating in a report on Friday, November 9th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $72.60.
Shares of Amdocs stock opened at $60.29 on Friday. Amdocs has a 12-month low of $60.28 and a 12-month high of $71.72. The stock has a market capitalization of $9.15 billion, a PE ratio of 16.12, a PEG ratio of 1.92 and a beta of 0.51.
The company also recently declared a quarterly dividend, which will be paid on Friday, January 18th. Stockholders of record on Monday, December 31st will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.66%. The ex-dividend date is Friday, December 28th. Amdocs’s payout ratio is 26.74%.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Fort L.P. purchased a new stake in Amdocs in the second quarter valued at approximately $118,000. Honkamp Krueger Financial Services Inc. purchased a new stake in Amdocs in the third quarter valued at approximately $124,000. Dynamic Technology Lab Private Ltd purchased a new stake in Amdocs in the second quarter valued at approximately $205,000. Capital Fund Management S.A. purchased a new stake in Amdocs in the second quarter valued at approximately $218,000. Finally, Fuller & Thaler Asset Management Inc. raised its stake in Amdocs by 115.8% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 4,100 shares of the technology company’s stock valued at $271,000 after purchasing an additional 2,200 shares in the last quarter. 91.15% of the stock is currently owned by institutional investors and hedge funds.
Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.
Recommended Story: What is a Futures Contract?
Get a free copy of the Zacks research report on Amdocs (DOX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.